Business Practices Committee
The ILTS Business Practices Committee is working to develop comprehensive best practices and guidelines for Liver Transplantation Centers worldwide.
Key aims of the Business Practices Committee:
- Collaboratively formulate best practices that reflect the highest standards in Liver Transplantation Center operations.
- Develop guidelines encompassing various aspects, from patient care and safety to administrative efficiency and innovation.
- Provide a roadmap for new and developing centers, assisting them in their growth journey and alignment with industry standards.
Committee Members:
- Markus Selzner, MD – Chair {2026} UHN Toronto, Canada
- Dieter Broering, MD, PhD, FEBS, FACS – Vice Chair {2027} King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
- Alfred Kow Wei Chieh, MBBS, MRCS, FRCS, FAMS, FACS– Affiliated Councilor {2027} – National University Health System, Singapore, Singapore
- Albert Chan, MBBS, MS, FRCS, FCSHK, FHKAM {2026} Liver Transplant Center, Queen Mary Hospital, The University of Hong Kong
- Daniel Maluf, MD{2026} University of Maryland, Baltimore, USA
- Audrey Dillon {2026} St Vincent’s University Hospital, Dublin, Ireland
- Martin Dib {2026} Division of Transplantation, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA USA; Harvard Medical School USA
- Kymberly Watt, MD {2026} Mayo Clinic, Rochester, MN, USA
- Abed Khalaileh, MD, PhD {2026} Hadassah Hebrew University Medical Center, Jerusalem, Israe
- Xiao Xu {2026} Zhejiang University School of Medicine & Hangzhou Medical College, Hangzhou, China
- Sathish Kumar {2026} University of Michigan Medical Center, Ann Arbor, USA
- Amit Mathur, MD, MS, FACS {2026} Mayo Clinic, Phoenix, USA
- Madhukar Patel MD, MBA, ScM {2026} University of Texas Southwestern Medical Center, Texas, USA
- Julie Heimbach {2026} Mayo Clinic, Rochester, USA
- Goutham Kumar {2027} Sparsh Hospital, India
*Committee terms end at Annual Congress in the year shown in brackets*
|
